Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
Hong Kong · Delayed Price · Currency is HKD 4.405
+0.005 (0.11%)
Sep 30, 2026, 10:06 AM HKT
Jiangsu Recbio Technology Market Cap
Jiangsu Recbio Technology has a market cap or net worth of 2.72 billion as of October 1, 2026. Its market cap has decreased by -24.33% in one year.
Market Cap
2.72B
Enterprise Value
3.28B
Revenue
568.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
4.41
ChartMarket Cap Chart
Since March 31, 2022, Jiangsu Recbio Technology's market cap has decreased from 12.10B to 2.72B, a decrease of -77.54%. That is a compound annual growth rate of -28.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 2.72B | 10.13% |
| Dec 31, 2025 | 2.47B | -45.80% |
| Dec 31, 2024 | 4.55B | -12.74% |
| Dec 29, 2023 | 5.22B | -56.10% |
| Dec 30, 2022 | 11.88B | -1.79% |
| Mar 31, 2022 | 12.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Viva Biotech Holdings | 2.96B |
| Medtide | 2.94B |
| BioDlink International Company | 2.86B |
| Laekna | 2.71B |
| Beijing Luzhu Biotechnology | 2.69B |
| HJ Science | 2.66B |
| Clover Biopharmaceuticals | 2.44B |
| Frontage Holdings | 2.40B |